http://www.otonomy.com
Otonomy, Inc. Company Intro
Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings of frustration, decreased social interaction and depression. At Otonomy, our focus is on making new treatments a reality for the millions living with the debilitating, daily impact of these conditions.
Industry
Healthcare
Otonomy, Inc. Headquaters
4796 Executive Drive
San Diego,92121
United States
Otonomy, Inc. Share price
22 Oct 2020 02:17 GMT
$3.7000
-0.01 (-0.27 %)
Otonomy, Inc. Market cap
$178.924 M
WMC RANKING
2020
Otonomy, Inc. # 238
BiotechnologyLatest Otonomy, Inc. News
22 Oct 2020
Meniere Disease Drugs Market Size, Share, Scope, Growth ...
Otonomy Inc; Quark Pharmaceuticals Inc; Sound Pharmaceuticals Inc; Synphora AB. The final report will add the analysis of the impact of Covid-19 in this Meniere ...
22 Oct 2020
Global Meniere Disease Drugs Market 2020 Business Strategies – Orbis Biosciences Inc, Sound Pharmaceuticals Inc, Otonomy Inc, Quark Pharmaceuticals Inc
Global Meniere Disease Drugs Market 2020 Business Strategies – Orbis Biosciences Inc, Sound Pharmaceuticals Inc, Otonomy Inc, Quark Pharmaceuticals Inc.
22 Oct 2020
Meniere Disease Drugs Market Size, Share, Scope, Growth ...
Orbis Biosciences Inc; Otonomy Inc; Quark Pharmaceuticals Inc; Sound ... supply/demand, import/export, broken down by company and country as well as by ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Otonomy, Inc. | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Otonomy, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Otonomy, Inc. | $600 | $44,495 | $-44,675 | $178.924M | 238 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |